Anna Filardo's Contact Details

Anna Filardo's Company Details

Drug Free Sport International

Kansas City, Missouri, US • 78 Employees
Healthcare Facility/Healthcare Services

ANTI-DOPING Drug Free Sport International (DFSI) is the global leader and innovator of anti-doping solutions and health education for sport with a focus in advocating for athletes and their quest for safe and fair competition. DFSI and International Doping Tests & Management (IDTM), out of Stockholm, Sweden, merged in 2018 forming the largest third-party sport anti-doping administrator in the world. DFSI and IDTM clients have access to a specimen collection footprint that spans over 100 countries, enabling DFSI to efficiently accomplish any mission, any time and nearly anywhere in the world. DFSI provides professional anti-doping solutions for sport organizations all over the world including MLB, the NFL, the NBA, NASCAR, the PGA Tour, the LPGA, the International Tennis Federation, the IAAF, FINA, the NCAA, and more than 300 colleges, universities, and amateur athletics organizations globally. RESEARCH & HEALTHCARE SERVICES For more than three decades, our sophisticated infrastructure and processes have met the elite demands of Olympic athletes and world-class competitors, adhering to the strictest international standards at the apex of human performance. Today, DFSI Research & Healthcare Services leverages this vast network and deep specimen collection expertise to accelerate groundbreaking advancements in diagnostics and pharmaceutical development. Our worldwide collection network boasts a proven track record, featuring a complete continuum of licensed medical professionals proficient in Good Clinical Practice. These experts are dedicated to delivering exceptional service levels to clients, researchers, and patients alike, and our robust procedures guarantee unparalleled regulatory compliance and quality assurance. Services included: - Decentralized clinical trials with flexible at-home and event-based visits. - Re-engaged lost participants through targeted follow-up visits. - Global sample collection tailored to critical patient populations.